• GeoVax entered a warrant inducement deal for immediate exercise of existing warrants for 5,697,628 shares at USD 0.64.
• Gross proceeds expected at about USD 3.65 million; net funds earmarked for working capital, general corporate purposes.
• Investors to receive new unregistered warrants for 11,395,256 shares at USD 0.64 in a private placement.
• New warrants become exercisable upon shareholder approval; expiry set five years from the approval date.
• Closing targeted around Aug. 27, 2026, subject to customary conditions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GeoVax Labs Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-029181), on August 28, 2026, and is solely responsible for the information contained therein.